Statistics

Total Visits

Views
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER) 36

Total Visits Per Month

June 2022 July 2022 August 2022 September 2022 October 2022 November 2022 December 2022
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER) 0 14 11 3 4 4 0

File Visits

Views
albanell-ejc-rand.pdf 31

Top country views

Views
Sweden 13
United States 10
Spain 8
Germany 2
Iran 2
United Kingdom 1

Top cities views

Views
Barcelona 4
Ashburn 2
Pamplona 2
Ann Arbor 1
El Prat De Llobregat 1
Halle 1
Potsdam 1
Roquetas De Mar 1
San Ramon 1

Search DSpace


Advanced Search

Browse

My Account

Statistics

Compliant to Partaking